Japanese Foundation for Cancer Research
3/20

3Japan’s frontrunner in cancer care and research for more than a centuryJFCR was founded in 1908 as the rst cancer-specializing organization in Japan. Under its basic principle, “To Improve the Well-being of People Everywhere by Achieving Better Cancer Control,? JFCR established its research institute and hospital in 1934 to conduct wide-ranging cancer studies. Since then, JFCR has been playing a proactive role in cancer care and research in Japan, as is shown in JFCR milestones ranging from the understanding of molecular mechanisms of cancer onset to the development of innovative diagnostic and therapeutic methods. As a cancer-specializing medical organization accommodating both a research institute and a hospital, JFCR strives to achieve cancer control while maintaining its high vision and independence as an organization. Japan’s largest hospital specializing in cancer careThe Cancer Institute Hospital has 700 beds, and in fiscal 2011 it treated 61,324 outpatients and 9,690 inpatients. With more than 7,000 surgeries performed annually, the Hospital is proud to conduct the largest number of surgeries in Japan, especially those for stomach, breast, and colon cancers.  The Hospital’s Ambulatory Treatment Center is also known as Japan’s largest outpatient chemotherapy facility. Moreover, in radiation therapy the Hospital offers very accurate and low-invasive treatment, such as intensity-modulated radiation therapy (IMRT), by making use of the highest-quality equipment and technology. A team of oncologists at the Hospital specializes in treating various cancers, including advanced cancer, specific rare cancers, and refractory cancer, and provides patients with individualized cancer care that best ts each patient. Acclaimed globally for cancer research accomplishmentsJFCR has always been a pioneer in basic cancer research, not only in Japan but also on a global basis. The Cancer Institute, which has been playing the main role in JFCR research, started working on genetic recombination in the 1970s and led the world by succeeding in cloning the interferon gene. With further achievements, including isolation of the human T-cell leukemia virus type 1 (HTLV-1), identication of anti-cancer drug resistance genes, and clarication of mechanisms of human cancer development, the Institute has attracted the world’s attention and was listed as one of the world’s leading cancer research institutes in Science magazine in 1992.  Alongside the Institute, JFCR’s Cancer Institute Hospital, Cancer Chemotherapy Center, and Genome Center promote integrated cancer research, from basic scientic investigation to clinical applications.

?のペ?ジ 

10秒後に?のペ?ジに移動しま?

※こ?ペ?ジを正しく表示するにはFlashPlayer10.2以上が?要で?